A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Bezlotoxumab | Bezlotoxumab (BLA761046; MBL-CDB1; MDX-1388) is a fully humanized IgG1/kappa monoclonal antibody directed against Clostridium difficile toxin B. Bezlotoxumab mediates the early reconstitution of gut microbiota to reduce the risk of recurrent Clostridium difficile infection (CDI). Bezlotoxumab can be used for the study of recurrent Clostridium difficile infection prevention[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BLA761046; MBL-CDB1; MDX-1388. CAS No. 1246264-45-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9929. |  |
| Bezuclastinib | Bezuclastinib (CGT9486) is an orally active, highly selective tyrosine kinase inhibitor with potent activity against KIT D816V. Bezuclastinib can be used for the research of nonadvanced systemic mastocytosis (NonAdvSM)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CGT9486; PLX 9486. CAS No. 1616385-51-3. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-145557. | |
| Bezuclastinib | Bezuclastinib, a tyrosine kinase inhibitor, is a potent c-kit and c-kit D816V inhibitor (0.0001| |  |
| BF-168 | BF-168, a candidate probe for PET, is found to specifically recognize both neuritic and diffuse plaques, with a Ki of 6.4 nM for Aβ1-42. Uses: Scientific research. Category: Signaling pathways. CAS No. 634911-47-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-112830. | |
| BF-168 | BF-168 is a candidate probe for PET and specifically recognizes both neuritic and diffuse plaques (Ki = 6.4 nM for A1-42). Synonyms: BF 168; 6-(2-fluoroethoxy)-2-(2-(4-methylaminophenil)ethenyl)benzoxazole. Grade: 99%. CAS No. 634911-47-0. Molecular formula: C18H17FN2O2. Mole weight: 312.34. | |
| BF-170 | BF-170 is a selective tau fibril binding agent with an EC50 of 221 nM. It exhibits good blood-brain barrier permeability, and after intravenous injection in mice, the concentration in brain tissue reaches 9.1% ID/g within 2 minutes (with a brain clearance rate of 0.25% ID/g after 30 minutes). BF-170 can be used as a probe for tau protein pathology imaging in Alzheimer's disease (AD). It plays an important role in early-stage AD research and holds potential for imaging studies of tau-related neurodegenerative diseases[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 22191-97-5. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-W338446. | |
| BF 227 | BF 227 is a candidate used for diagnostic imaging of diseases with amyloid β protein accumulation. Synonyms: BF-227; BF227; 2-[2-(2-dimethylaminothiazol-5-yl-)ethenyl]-6-[2-fluoroethoxy]benzoxazole. CAS No. 845647-80-5. Molecular formula: C16H16FN3O2S. Mole weight: 333.38. | |
| BF 2649 | Pitolisant hydrochloride is an antagonist of the histamine H3 receptor, which is used for the treatment of narcolepsy with or without cataplexy in adult patients. Uses: The treatment of narcolepsy with or without cataplexy. Synonyms: BF 2649; BF2649; BF-2649; pitolisant hydrochloride; Wakix; 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine hydrochloride. CAS No. 903576-44-3. Molecular formula: C17H27Cl2NO. Mole weight: 332.309. | |
| BF 2649 hydrochloride | BF 2649 hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 903576-44-3. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. |  Worldwide |
| BF738735 | A potent and selective ATP-competitive phosphatidylinositol 4-kinase III beta (PI 4-KIIIβ) inhibitor (IC50 = 5.7 nM). Displays approximately 200-fold selectivity over PI 4-KIIIα. Broad spectrum enterovirus replication inhibitor. Synonyms: 1436383-95-7; BF738735; 2-fluoro-4-(2-methyl-8-((3-(methylsulfonyl)benzyl)amino)imidazo[1,2-a]pyrazin-3-yl)phenol; CHEMBL2407818; 2-fluoro-4-[2-methyl-8-[(3-methylsulfonylphenyl)methylamino]imidazo[1,2-a]pyrazin-3-yl]phenol; BF 738735; C21H19FN4O3S; GLXC-25537; BDBM50492527; HY-U00426; MFCD31619316; AKOS040742416; DA-61637; SY125659; WS-01993; CS-0035356; W15611; 2-Fluoro-4-[2-methyl-8-[[3-(methylsulfonyl)benzyl]amino]-3-imidazo[1,2-a]pyrazinyl]phenol; 2-fluoro-4-(8-{[(3-methanesulfonylphenyl)methyl]amino}-2-methylimidazo[1,2-a]pyrazin-3-yl)phenol. Grade: ≥98%. CAS No. 1436383-95-7. Molecular formula: C31H57N5O9. Mole weight: 643.8. | |
| BF738735 | BF738735 is a phosphatidylinositol 4-kinase III beta (PI4KIIIβ) inhibitor with an IC50 of 5.7 nM. Uses: Scientific research. Category: Signaling pathways. CAS No. 1436383-95-7. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-U00426. | |
| BF844 | BF844 is a CLRN1N48K stabilizer that can attenuate progressive hearing loss and deafness in an Usher syndrome type III (USH3) mouse model. Uses: Hearing loss therapy. Synonyms: BioFocus 844; BioFocus844; BioFocus-844; BF844; BF-844; BF 844; 4-Chloro-α,α-dimethyl-3,5-diphenyl-1H-pyrazolo[3,4-c]pyridazine-1-ethanol. Grade: 98%. CAS No. 1404506-35-9. Molecular formula: C21H19ClN4O. Mole weight: 378.85. | |
| B-factor | B-factor is extracted from yeast. Synonyms: 3'-(1-Butylphosphoryl)adenosine; 3'-Adenylic acid, monobutyl ester. CAS No. 52278-63-4. Molecular formula: C14H22N5O7P. Mole weight: 403.33. | |
| BFCAs-1 | BFCAs-1 is a polyamino polycarboxylic bifunctional chelating agent, which has a broad range of applications in chemistry, biology and medicine and diagnostic imaging. Grade: >98%. CAS No. 585531-74-4. Molecular formula: C32H60N4O8. Mole weight: 628.84. | |
| BF-CATH | Cathelicidin-BF is a short antimicrobial peptide, which was originally extracted from the venom of Bungarus fasciatus. Recent studies have reported that Cath-BF and some related derivatives exert strong antimicrobial and weak hemolytic properties. Synonyms: Cath-BF. | |
| BFF 122 | BFF 122 is a potent and selective inhibitor of kynurenine aminotransferase II (IC50 = 1 μM and >30 μM for KAT II and KAT I respectively). Synonyms: BFF122; BFF 122; BFF-122; BF5; (S)-9-(4-Amino-piperazin-1-yl)-8-fluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid. Grade: 99%. CAS No. 1152314-49-2. Molecular formula: C17H19FN4O4. Mole weight: 362.36. | |
| bFGF (119-126) | bFGF (119-126) is a ligand of bFGF. The complex formed by bFGF (119-126) and bFGF can bind to FGFR1, while inhibiting the bFGF-FGFR1 interaction, FGFR1 phosphorylation and downstream signaling pathways. Therefore, bFGF (119-126) induces cell apoptosis and inhibits cell proliferation, migration, angiogenesis and metastasis. When conjugated with a carrier, bFGF (119-126) enhances cellular uptake via FGFR-mediated endocytosis and serves as an effective FGFR-targeted ligand. When used in combination with ultrasound and Doxorubicin (HY-15142A), bFGF (119-126) significantly enhances the inhibitory effect on tumors. bFGF (119-126) is applicable to research related to lung cancer, breast cancer, glioblastoma and ovarian cancer[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 152051-61-1. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P5321. | |
| BFH772 | BFH772, a structure analogue of BAW2881, was highly effective at targeting VEGFR2 kinase with an IC50 value of 3 nM, however, lost 500-fold potency on FLK-1, FLT-1, and FLT-4. BFH772 inhibits the ligand induced autophosphorylation of RET, PDGFR, and KIT kinases, with IC50 values ranging between 30 and 160 nM. Synonyms: 6-[[6-(hydroxymethyl)-4-pyrimidinyl]oxy]-N-[3-(trifluoromethyl)phenyl]-1-naphthalenecarboxamide; BFH-772; BFH 772; BFH772; 1-Naphthalenecarboxamide, 6-((6-(hydroxymethyl)-4-pyrimidinyl)oxy)-N-(3-(trifluoromethyl)phenyl)-. CAS No. 890128-81-1. Molecular formula: C23H16F3N3O3. Mole weight: 439.4. | |
| b-Fluoro-DL-alanine | b-Fluoro-DL-alanine. Group: Biochemicals. Grades: Highly Purified. CAS No. 43163-93-5. Pack Sizes: 100mg, 250mg, 500mg, 1g, 2g. Molecular Formula: C3H6FNO2. US Biological Life Sciences. | Worldwide |
| b-Fluoro-DL-alanine ≥97% (GC) | b-Fluoro-DL-alanine ≥97% (GC). Group: Biochemicals. Grades: GC. Pack Sizes: 100mg, 250mg, 25mg, 1g. US Biological Life Sciences. | Worldwide |
| BG45 | BG45 is a class I HDAC inhibitor with IC50 of 289 nM, 2.0 μM, 2.2 μM and >20 μM for HDAC3, HDAC1, HDAC2, and HDAC6 in cell-free assays, respectively. Synonyms: BG45; BG-45; BG 45. Grade: 98%. CAS No. 926259-99-6. Molecular formula: C11H10N4O. Mole weight: 214.22. | |
| b-Galactosyl 1-3 N-acetyl galactosamine methyl glycoside | b-Galactosyl 1-3 N-acetyl galactosamine methyl glycoside is a sophisticated compound, functioning as an artfully engineered synthetic glycoside. Thereby, it orchestrates nuanced manipulation of cellular processes instrumental in compound administration, focused therapeutics, or malady identification. Synonyms: Methyl 2-acetamido-2-deoxy-3-O-(b-D-galactopyranosyl)-b-D-galactopyranoside; β-Galactosyl 1-3 N-acetyl galactosamine methyl glycoside; N-Acetyl-3-O-beta-D-galactopyranosyl-beta-D-galactosamine methyl glycoside; N-Acetyl-3-O-β-D-galactopyranosyl-β-D-GA. Grade: ≥98%. CAS No. 88274-25-3. Molecular formula: C15H27NO11. Mole weight: 397.38. | |
| b-Galactosylceramides from bovine brain | b-Galactosylceramides from bovine brain, derived from the ample tissues of bovine brain, stand as naturally occurring glycosphingolipids. Their intrinsic attributes have unveiled a realm of possibilities in biomedical research, particularly delving into the intricate realm of immune responses and tumor development. Synonyms: Ceramide b-D-galactosides; Cerebrosides. CAS No. 85305-88-0. Molecular formula: C48H93NO9. Mole weight: 828.3. | |
| BGB-283 | BGB-283 is a selective Epidermal growth factor receptor and Proto oncogene protein b raf inhibitor under the development of BeiGene. BGB-283 shows antitumor activity in B-RAF Mutated Colorectal Cancers. In vitro, BGB-283 can inhibit B-RAFV600E-activated ERK phosphorylation and cell proliferation. In vivo, BGB-283 can lead to dose-dependent tumor growth inhibition accompanied by partial and complete tumor regressions in both cell-line derived and primary human colorectal tumor xenografts bearing B-RAFV600E mutation. Phase I clinical trials for the treatment of solid tumours are on-going. Uses: Solid tumours. Synonyms: UNII-8762XZS5ZF; 8762XZS5ZF; BGB-283; BGB 283; BGB283; Beigene-283; Beigene283; Beigene 283; Lifirafenib; Compound 2.2b; Beigene-283; GTPL8958; 5-[[(1R,1aS,6bR)-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one. Grade: 98%. CAS No. 1446090-77-2. Molecular formula: C25H17F3N4O3. Mole weight: 478.31. | |
| BGC-20-1531 | BGC-20-1531 is a high-affinity and selective EP4 antagonist (Ki = 3 nM). BGC-20-1531 has the potential for the treatment of migraine headache. Synonyms: BGC 20-1531; BGC201531; BGC-201531; BGC 201531; GTPL3380; GTPL-3380; GTPL 3380; AP-1531; AP1531; AP1531. Grade: >98%. CAS No. 1186532-61-5. Molecular formula: C26H23N2NaO6S. Mole weight: 514.53. | |
| BGC-20-1531 free base | BGC-20-1531 is a selective EP4 receptor antagonist with a pKB of 7.6. BGC-20-1531 free base has the potential for the research of migraine headache. Synonyms: BGC-201531; PGN 1531 free base; 4-[[4-(5-Methoxy-2-pyridinyl)phenoxy]methyl]-5-methyl-N-[(2-methylphenyl)sulfonyl]-2-furancarboxamide. Grade: 98%. CAS No. 736183-35-0. Molecular formula: C26H24N2O6S. Mole weight: 492.54. | |
| BGC 20-1531 hydrochloride | BGC 20-1531 hydrochloride is a potent and selective EP4 antagonist, which exhibits <50% inhibition at 47 ion channels, cell-surface transporters, enzymes, and nuclear receptors. It has high affinity and selective with Ki of 3 nM for EP4 antagonist. BGC 20-1531 antagonizes PGE2-induced cAMP accumulation in a dose-dependent manner in HEK293 EBNA. It also reverses PGE2-induced vasorelaxation with Kb of 15.85 nM in human middle cerebral and middle meningeal arterial rings. Synonyms: BGC20-1531 HCl; BGC20-1531 hydrochloride; BGC20-1531; BGC 20-1531; BGC-20-1531; BGC201531; BGC 201531; BGC-201531; PGN 1531; PGN-1531; PGN1531. Grade: ≥98%. CAS No. 1962928-26-2. Molecular formula: C26H24N2O6S·HCl. Mole weight: 529. | |
| BGC 20-761 | BGC 20-761 is a selective, high affinity 5-HT6 antagonist (Ki = 20 nM). BGC 20-761 was shown to reverse the amnesic effects of scopolamine and enhance memory consolidation in a rat model. Synonyms: BGC-20-761; BGC 20 761; 5-Methoxy-N,N-dimethyl-2-phenyl-1H-indole-3-ethanamine; N,N-Dimethyl-2-(5-methoxy-2-phenylindol-3-yl)ethylamine. Grade: ≥98% by HPLC. CAS No. 17375-63-2. Molecular formula: C19H22N2O. Mole weight: 294.39. | |
| BGC 20-761 | BGC 20-761. Group: Biochemicals. Grades: Purified. CAS No. 17375-63-2. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| BGC-638 | BGC-638, an analogue of BGC-945, is a thymidylate synthase inhibitor specifically transported into α-folate receptor (α-FR)-overexpressing tumors. Synonyms: BGC 638; BGC638; CB300638; CB-300638; D-Glutamic acid, N-(4-(2-propyn-1-yl((6S)-4,6,7,8-tetrahydro-2-methyl-4-oxo-3H-cyclopenta(g)quinazolin-6-yl)amino)benzoyl)-L-gamma-glutamyl-. CAS No. 416852-27-2. Molecular formula: C32H33N5O9. Mole weight: 631.64. | |
| BGC-945 | BGC 945 is a cyclopenta[g]quinazoline-based, thymidylate synthase inhibitor specifically transported into α-folate receptor (α-FR)-overexpressing tumors. BGC 945 has low affinity for the widely expressed reduced-folate carrier (RFC). BGC 945 selectively inhibits thymidylate synthase in α-FR-overexpressing tumors and should cause minimal toxicity to humans at therapeutic doses. Synonyms: Idetrexed; ONX-0801; N-[4-[2-Propynyl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-1H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-L-γ-glutamyl-D-glutamic acid; N-[4-[2-Propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-L-γ-glutamyl-D-glutamic acid; (R)-2-((S)-4-carboxy-4-(4-(((S)-2-(hydroxymethyl)-4-oxo-4,6,7,8-tetrahydro-3H-cyclopenta[g]quinazolin-6-yl)(prop-2-yn-1-yl)amino)benzamido)butanamido)pentanedioic acid. Grade: ≥95%. CAS No. 501332-69-0. Molecular formula: C32H33N5O10. Mole weight: 647.63. | |
| BGDA | BGDA. |  |
| b-Gentiobiose octaacetate | b-Gentiobiose octaacetate is a biomedical compound employed extensively in drug development and research, predominantly recognized as a safeguarding tool for delicate pharmaceuticals. This compound remarkably aids drug delivery and augments stability. Moreover, its application extends to the investigation of ailments such as cancer, diabetes and neurodegenerative disorders, thereby effectively unraveling their intricate mechanisms and potential researchs. Synonyms: 1,2,3,4-Tetra-O-acetyl-6-O-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)-b-D-glucopyranose; β-D-Glucopyranose, 6-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-, 1,2,3,4-tetraacetate; Gentiobiose octaacetate; β-D-Glucopyranose, 6-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-, tetraacetate; β-Gentiobiose octaacetate. CAS No. 4613-78-9. Molecular formula: C28H38O19. Mole weight: 678.59. | |
| BGJ-398 | BGJ398, also known as NVP-BGJ398, is a pan FGFR kinase inhibitor, and is an orally bioavailable pan inhibitor of human fibroblast growth factor receptors (FGFRs) with potential antiangiogenic and antineoplastic activities. BGJ398 selectively binds to and inhibits the activities of FGFRs, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. Synonyms: 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea; NVPBGJ398; NVPBGJ 398; NVPBGJ-398; BGJ398; BGJ-398; BG J398; Infigratinib. Grade: 0.98. CAS No. 872511-34-7. Molecular formula: C26H31Cl2N7O3. Mole weight: 560.48. | |
| BGJ398 (Infigratinib) | Infigratinib (BGJ398) is a potent and selective FGFR inhibitor for FGFR1/2/3 with IC50 of 0.9 nM/1.4 nM/1 nM in cell-free assays, >40-fold selective for FGFR versus FGFR4 and VEGFR2, and little activity to Abl, Fyn, Kit, Lck, Lyn and Yes. Phase 2. Group: Inhibitors. Alternative Names: NVP-BGJ398. CAS No. 872511-34-7. Pack Sizes: 5mg. Product ID: S2183. Formula: C26H31Cl2N7O3. Smiles: CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl. Storage Conditions: 2 years -80 in solvent. |  United States; Europe |
| BG-JF585 | BG-JF585 is Benzylguanine-conjugated JF585 (HY-131025). Benzylguanine is the substrate for SNAP tags. JF585 is a fluorophore (λabs: 593 nm; λem: 611 nm). Uses: Scientific research. Category: Signaling pathways. Alternative Names: SNAP-JF585. CAS No. 2461569-42-4. Pack Sizes: 500 μg; 1 mg; 5 mg. Product ID: HY-D2929. | |
| Bgl I | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 20-fold overdigestion with enzyme more than 90% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 500U; 2500U. GCCNNNN↑NGGC CGGN↓NNNNCCG. Activity: 5000-10000u.a./ml. Appearance: 10 X SE-buffer 2W. Storage: -20°C. Form: Liquid. Source: Bacillus globigii. Pack: 10 mM Tris-HCl (pH 7.5); 200 mM NaCl; 0.1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA; 50% glycerol. Cat No: ET-1033RE. |  |
| Bgl II | One unit of the enzyme is the amount required to hydrolyze 1 μg of Lambda DNA in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 10-fold overdigestion with enzyme more than 90% of the dna fragments can be ligated and recut. Group: Restriction Enzymes. Purity: 1000U; 5000U. A↑GATCT TCTAG↓A. Activity: 10000u.a./ml. Appearance: 10 X SE-buffer O. Storage: -20°C. Form: Liquid. Source: An E.coli strain that carries the cloned Bgl II gene from Bacillus globigii. Pack: 10 mM Tris-HCl (pH 7.5); 50 mM NaCl; 0,1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA; 50% glycerol. Cat No: ET-1034RE. | |
| b-Glucosylglycerol 2,3,4,6-tetraacetate | b-Glucosylglycerol 2,3,4,6-tetraacetate, a remarkable compound, exhibits immense potential as an antidiabetic agent. In the realm of diabetes management, this prodigious specimen reigns, adeptly regulating blood glucose levels and fostering insulin sensitivity enhancement. Beyond its primary scope, it gracefully unveils itself as a viable therapeutic alternative for diverse metabolic afflictions. Synonyms: 2-(Tetraacetylglucosido)glycerol; 2-Hydroxy-1-(hydroxymethyl)ethyl b-D-glucopyranoside 2,3,4,6-tetraacetate; 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl glycerol; Glycerol, 2-(tetraacetylglucosido)-; β-D-Glucopyranoside, 2-hydroxy-1-(hydroxymethyl)ethyl, 2,3,4,6-tetraacetate. CAS No. 157024-67-4. Molecular formula: C17H26O12. Mole weight: 422.38. | |
| b-Glutamic acid hydrochloride 98+% (TLC) | b-Glutamic acid hydrochloride 98+% (TLC). Group: Biochemicals. Grades: Reagent Grade. CAS No. 336182-10-6. Pack Sizes: 100mg, 250mg, 1g, 5g. US Biological Life Sciences. | Worldwide |
| b-Glycerophosphate Disodium Salt Hydrate 99+% | Used as an organic phosphate donor and to buffer cell culture media. Group: Biochemicals. Alternative Names: Glycerol 2-phosphate disodium salt hydrate. Grades: Reagent Grade. CAS No. 154804-51-0. Pack Sizes: 5g, 25g, 100g, 250g. Molecular Formula: C3H7Na2O6P; xH2O, Molecular Weight: 234. US Biological Life Sciences. | Worldwide |
| b-Glycerophosphoric acid disodium salt pentahydrate | b-Glycerophosphoric acid disodium salt pentahydrate. Group: Biochemicals. Alternative Names: Disodium b-glycerophosphate pentahydrate; Glycerol 2-phosphate disodium salt pentahydrate. Grades: Highly Purified. CAS No. 819-83-0. Pack Sizes: 25g, 50g, 100g, 250g, 500g. Molecular Formula: C3H7O6P·2Na·5H2O. US Biological Life Sciences. | Worldwide |
| BGN3 | BGN3 is a good substrate for the SNAP-tag? and H5 enzymes. The activities of SNAP-tag? and H5 enzymes on BGN3 are reasonable (IC50= 15.6 and 23.5 μM, respectively)[1]. BGN3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups. Uses: Scientific research. Category: Signaling pathways. CAS No. 1151762-33-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-139162. | |
| BG-NH2 | BG-NH2 is a pharmaceutical intermediate. BG-NH2 is suitable for synthesizing fluorescent SNAP tag substrates to label RNA[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: SNAP-NH2. CAS No. 674799-96-3. Pack Sizes: 10 mM * 1 mL in DMSO; 100 mg; 250 mg; 500 mg; 1 g. Product ID: HY-W017776. | |
| BGP-15 | BGP-15 is a PARP inhibitor, with an IC50 and a Ki of 120 and 57 μM, respectively. Uses: Enzyme inhibitors. Synonyms: BGP15; BGP 15; 3-Pyridinecarboximidamide, N-(2-hydroxy-3-(1-piperidinyl)propoxy)-, hydrochloride (1:2). Grade: >98%. CAS No. 66611-37-8. Molecular formula: C20H40N4O3S3. Mole weight: 351.27. | |
| BGP-15 | BGP-15 is a PARP inhibitor, with an IC50 and a Ki of 120 and 57 μM, respectively. Uses: Scientific research. Category: Signaling pathways. CAS No. 66611-37-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100828. | |
| BGT1-IN-1 | BGT1-IN-1 (compound 9) is a potent BGT1 inhibitor with IC50 value of 13.9, 58.3 μM for hBGT1, GAT3, respectively. BGT1-IN-1 shows no cytotoxic. BGT1-IN-1 shows neuroprotective activity[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 406947-32-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg. Product ID: HY-W033027. | |
| BGT226 | BGT226 is a phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BGT226 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, which may trigger the translocation of cytosolic Bax to the mitochondrial outer membrane, increasing mitochondrial membrane permeability. Synonyms: BGT-226; BGT 226; BGT-226 free base; BGT226 free base; NVP-BGT226; 1,3-Dihydro-8-(6-methoxy-3-pyridinyl)-3-methyl-1-[4-(1-piperazinyl)-3-(trifluoromethyl)phenyl]-2H-imidazo[4,5-c]quinolin-2-one. Grade: 98%. CAS No. 915020-55-2. Molecular formula: C32H29F3N6O6. Mole weight: 534.54. | |
| BGT226 | BGT226 (NVP-BGT226) is a PI3K (with IC50s of 4 nM, 63 nM and 38 nM for PI3Kα, PI3Kβ and PI3Kγ)/mTOR dual inhibitor which displays potent growth-inhibitory activity against human head and neck cancer cells[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: NVP-BGT226. CAS No. 915020-55-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13334A. | |
| BGT226 maleate | BGT226 (NVP-BGT226 maleate) is a PI3K (with IC50s of 4 nM, 63 nM and 38 nM for PI3Kα, PI3Kβ and PI3Kγ) /mTOR dual inhibitor which displays potent growth-inhibitory activity against human head and neck cancer cells[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: NVP-BGT226 maleate. CAS No. 1245537-68-1. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13334. | |
| BH3I-1 | BH3I-1 is a cell-permeable inhibitor that targets Bcl-2 family protein. It inhibits the binding of BH3 peptides to Bcl-xL and induces apoptosis of Bcl-xL expressing cells. Synonyms: BH3I-1; BH 3I-1; BH-3I-1; BH3I1; BH 3I1; BH-3I1. 2-[(5E)-5-[(4-bromophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-methylbutanoic acid. Grade: 99%. CAS No. 300817-68-9. Molecular formula: C15H14BrNO3S2. Mole weight: 400.31. | |
| BHA | BHA (Butylated Hydroxy Anisole). CAS No. 25013-16-5. FEMA No. 2183. Kosher: Y. VIGON Item # 500563. Categories: Speciality Ingredients Suppliers, Flavors, Fragrances, Perfumers. |  America & Internationally |
| BHA-polystyrene | BHA-polystyrene. | |
| Bhimamycin A | Bhimamycin is an antibiotic produced by Streptomyces sp. GW32/698. Five components A to E are separated. Bhimamycin A has moderate activity against gram-positive and gram-negative bacteria. Molecular formula: C15H12O5. Mole weight: 272.25. | |
| Bhimamycin B | Bhimamycin is an antibiotic produced by Streptomyces sp. GW32/698. Five components A to E are separated. Bhimamycin B has moderate activity against gram-positive and gram-negative bacteria. Molecular formula: C15H10O5. Mole weight: 270.24. | |
| Bhimamycin C | Bhimamycin is an antibiotic produced by Streptomyces sp. GW32/698. Five components A to E are separated. Bhimamycin C has no antibacterial activity. Molecular formula: C17H17NO5. Mole weight: 315.32. | |
| Bhimamycin D | Bhimamycin is an antibiotic produced by Streptomyces sp. GW32/698. Five components A to E are separated. Bhimamycin D has no antibacterial activity. Molecular formula: C22H15NO6. Mole weight: 389.36. | |
| Bhimamycin E | Bhimamycin is an antibiotic produced by Streptomyces sp. GW32/699. Five components A to E are separated. Bhimamycin E selectively inhibits Staphylococcus aureus. Molecular formula: C13H10O5. Mole weight: 246.21. | |
| BHP | BHP is an antibacterial peptide isolated from Bos taurus. | |
| BHPI | BHPI is a nuclear receptor ERα inhibitor. BHPI activates PLCγ and UPR. BHPI has antitumor activity against breast, endometrial, and ovarian cancers[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 56632-39-4. Pack Sizes: 10 mM * 1 mL in DMSO; 2 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 1 g. Product ID: HY-12825. | |
| BHPI | BHPI is an antagonist of estrogen receptor α (ERα), for it elicits sustained ERα-dependent activation of the endoplasmic reticulum (EnR) stress sensor. Uses: An antagonist of estrogen receptor α (erα). Synonyms: 1,3-dihydro-3,3-bis(4-hydroxyphenyl)-7-methyl-2H-indol-2-one. Grade: ≥95%. CAS No. 56632-39-4. Molecular formula: C21H17NO3. Mole weight: 331.4. | |
| BHQ-1-dT CE Phosphoramidite | BHQ-1-dT, a widely utilized reagent in the biomedicine realm, remains pertinent for nucleic acid detection and DNA sequencing. Its potential significance surfaces in disease and genetic disorder determination alongside viral load monitoring in infectious cases. From a development standpoint, BHQ-1-dT fosters therapeutic targeting of nucleic acids. Synonyms: BHQ-1-dT; HCQ-12-dT Phosphoramidite; 5'-Dimethoxytrityloxy-5-[(N-4''-carboxyethyl-4''-(N-ethyl)-4'-(2-Nitro-4-toluyldiazo)-2'-methoxy-5'-methyl-azobenzene)-aminohexyl-3-acrylimido]-2'-deoxyUridine-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; BHQ-1-dT Amidite. Grade: ≥95%. Molecular formula: C74H89N12O14P. Mole weight: 1401.56. | |
| BHQ-1 NHS | BHQ-1 NHS is a quencher and fluorescent dye. BHQ-1 NHS enables direct labeling via fluorescently labeled nucleotides[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 916753-61-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-154834. | |
| BHQ-2-dT | BHQ-2-dT plays a critical role in propelling PCR probes and hybridization assays to new heights of detection, this modified nucleoside serves as a beacon for identifying viral pathogens, genetic diseases, and cancer biomarkers. With its distinctive fluorescent abilities, molecular matching is taken to the next level of precision and accuracy, boosting sensitivity like never before. Synonyms: HCQ-2-dT Phosphoramidite; BHQ-2-dT CE Phosphoramidite; 5'-Dimethoxytrityloxy-5-[(N-4''-carboxyethyl-4''-(N-ethyl)-4'-(4-Nitro-phenyldiazo)-2'-methoxy-5'-methoxy-azobenzene)-aminohexyl-3-acrylimido]-2'-deoxyUridine-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; BHQ-2-dT Phosphoramidite; BHQ-2-dT Amidite. Grade: ≥95%. CAS No. 1415097-34-5. Molecular formula: C73H87N12O15P. Mole weight: 1403.53. | |
| BHQ-2 NHS | BHQ-2 NHS is a dark quencher with no native emission due to the polyaromatic-azo backbone and a terminal NHS ester. UBHQ-2 NHS has a wide and intense quenching range from 560-670 nm, which makes it useful as an acceptor in fluorescence resonance energy transfer (FRET) applications in conjunction with orange to far-red emitting dyes. The NHS ester can be applied to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. Uses: Scientific research. Category: Signaling pathways. CAS No. 916753-62-3. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-42984. | |
| BHT | BHT (Butylated Hydroxy Toluene). CAS No. 128-37-0. FEMA No. 2184. Kosher: Y. VIGON Item # 500473. Categories: Speciality Ingredients Suppliers, Flavors, Fragrances, Perfumers. | America & Internationally |
| B-HT 920 | B-HT 920. Group: Biochemicals. Grades: Purified. CAS No. 36085-73-1. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| B-HT 920 dihydrochloride | Talipexole is a D2 dopamine receptor agonist, displaying anti-Parkinsonian activity. Uses: A dopamine agonist, also an α2-adrenergic agonist. Synonyms: Talipexole; B-HT 920, B-HT-920, B-HT920, Talipexole HCl, Talipexole dihydrochloride, Domnin6-prop-2-enyl-4,5,7,8-tetrahydro-[1,3]thiazolo[4,5-d]azepin-2-amine; dihydrochloride; 5,6,7,8-Tetrahydro-6-(2-propenyl)-4H-thiazolo[4,5-d]azepine-2-amine dihydrochloride. Grade: ≥98%. CAS No. 36085-73-1. Molecular formula: C10H15N3S; 2HCl. Mole weight: 282.23. | |
| B-HT 920 dihydrochloride talipexole | B-HT 920 dihydrochloride talipexole. Group: Biochemicals. Alternative Names: 5,6,7,8-Tetrahydro-6-(2-propenyl)-4H-thiazolo[4,5-d]azepin-2-amine dihydrochloride, 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine dihydrochloride. Grades: Highly Purified. CAS No. 36085-73-1. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C10H17Cl2N3S. US Biological Life Sciences. | Worldwide |
| B-HT 920 Dihydrochloride. Talipexole (5,6,7,8-Tetrahydro-6-(2-propenyl)-4H-thiazolo[4,5-d]azepin-2-amine Dihydrochloride, 6-Allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine Dihydrochloride) | An alpha 2-Adrenoceptor and dopamine D2-receptor agonist. Used as an antiparkinson reagent. Group: Biochemicals. Alternative Names: 5,6,7,8-Tetrahydro-6-(2-propenyl)-4H-thiazolo[4,5-d]azepin-2-amine Dihydrochloride, 6-Allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine Dihydrochloride. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
